Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Express Scripts

Last Updated: January 28, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Sarcosine

See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Sarcosine?

Sarcosine is an investigational drug.

There have been 14 clinical trials for Sarcosine. The most recent clinical trial was a Phase 2 trial, which was initiated on September 1st 2012.

The most common disease conditions in clinical trials are Schizophrenia, Psychotic Disorders, and Mental Disorders. The leading clinical trial sponsors are China Medical University Hospital, National Science Council, Taiwan, and University of Aarhus.

There is one US patent protecting this investigational drug and eighteen international patents.

Recent Clinical Trials for Sarcosine
Effect of Obeticholic Acid on Transport of Bile Acids in PBC Examined by 11C-cholyl-sarcosine PET/CTUniversity of AarhusEarly Phase 1
Carbon-11 Labeled Sarcosine in Prostate CancerNational Cancer Institute (NCI)N/A
Carbon-11 Labeled Sarcosine in Prostate CancerNational Institutes of Health (NIH)N/A

See all Sarcosine clinical trials

Clinical Trial Summary for Sarcosine

Top disease conditions for Sarcosine
Top clinical trial sponsors for Sarcosine

See all Sarcosine clinical trials

US Patents for Sarcosine

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Sarcosine   Start Trial Di- or tripeptide renin inhibitors containing lactam conformational restriction in Achpa Merck & Co., Inc. (Rahway, NJ)   Start Trial
Sarcosine   Start Trial Delivery system Alza Corporation (Palo Alto, CA)   Start Trial
Sarcosine   Start Trial Method and articles employing ion exchange material Raychem Corporation (Menlo Park, CA)   Start Trial
Sarcosine   Start Trial Treatment of hypertension with 1,2,4-angiotensin II antagonists E. I. Du Pont de Nemours and Company (Wilmington, DE)   Start Trial
Sarcosine   Start Trial Method for dyeing polyester-containing fibers in an alkaline dyeing bath and dyeing assistant, an amino-acid compound Mitsubishi Kasei Corporation (Tokyo, JP)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Sarcosine

Drugname Country Document Number Estimated Expiration Related US Patent
Sarcosine European Patent Office 0312291 2007-10-14   Start Trial
Sarcosine Japan H01151597 2007-10-14   Start Trial
Sarcosine Austria 85519 2008-04-28   Start Trial
Sarcosine Canada 1337275 2008-04-28   Start Trial
Sarcosine Germany 68904801 2008-04-28   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.